Φορτώνει......
Underutilization of prophylactic rectal indomethacin and pancreatic duct stent for prevention of post-ERCP Pancreatitis
Background and study aims Incidence of Post-ERCP pancreatitis (PEP) ranges from 1 % to 10 % in unselected patients and as high as 25 % to 30 % in high-risk patients. Rectal indomethacin administered before or immediately after an ERCP and prophylactic pancreatic duct stent placement (PPS) are assoc...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Endosc Int Open |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Georg Thieme Verlag KG
2021
|
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8211473/ https://ncbi.nlm.nih.gov/pubmed/34222616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/a-1460-7776 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|